ETPharma.com brings latest pharmaceutical imports news, views and updates from all top sources for the Indian Pharma industry.

Despite a 30% cap on trade margins for non-scheduled cancer drugs, prices for branded cancer medications remain unchanged, ...

Despite a $2.2 billion setback due to failed drug trials, Novartis raises its profit forecast for the year, highlighting ...

The FDA has cautioned Amgen about a promotional video for Vectibix, its colorectal cancer drug, which allegedly ...

ETPharma.com brings latest regulatory filing news, views and updates from all top sources for the Indian Pharma industry.

The CDSCO has raised a public alert regarding a counterfeit batch of the liver medication Defitelio, prompting patients to ...

India's drug regulator DCGI cancels the import registration of FatX, a cosmetic product marketed with unauthorized ...

Cipla's bispecific ADC rolditamig deruxtecan demonstrates a remarkable 71% reduction in disease progression for late-stage ...

Cipla targets a first wave launch of its Keytruda biosimilar QL2107 in the US after patent expiry in 2029, with expectations ...

OneSource Specialty Pharma has reported a staggering 109% year-on-year increase in Q2 net profit for the second quarter ...

Mankind Pharma's net profit rises to ₹716 crore for Q2 FY27, driven by strong sales growth while seeking transformation in ...

Eli Lilly reveals significant leadership transitions as Patrik Jonsson announces retirement and Ilya Yuffa steps into the ...